TrialBMC infectious diseases2024

Efficacy and feasibility of a novel semi-facial respirator with chitosan nanoparticles on the incidence of SARS-CoV-2 infection in healthcare professionals: randomized controlled trial.

Aline Midori Adati Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.